SCHEMBL20112840

SCHEMBL20112840

CC(C)CCCC(=O)NCCC1CCOCC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
NAMPT P43490 3/20 0.37
CNR1 P21554 2/20 0.37
HPGD P15428 1/20 0.37
BCHE P06276 1/20 0.37
PIK3CD O00329 1/20 0.37
CNR2 P34972 1/20 0.36
CAPN1 P07384 1/20 0.36
CTSD P07339 1/20 0.35
PRMT3 O60678 1/20 0.34
USP2 O75604 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NMT1 P30419 3/20 0.34
NMT2 O60551 2/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15759098 0.84 ALDH1A1 (0.47) ALDH1A1PKMNAMPTHPGDBCHE
SCHEMBL11928030 0.81 ALDH1A1 (0.45) ALDH1A1NAMPTHPGDPRMT3USP2
SCHEMBL22735753 0.77 LMNA (0.50) ALDH1A1LMNAPKMNAMPTCNR1
SCHEMBL25925311 0.77 MEN1 (0.45) ALDH1A1PKMNAMPTHPGDPRMT3
SCHEMBL9891910 0.75 SIGMAR1 (0.43) ALDH1A1NAMPTBCHEPIK3CDCTSD
SCHEMBL13070014 0.75 ALDH1A1 (0.42) ALDH1A1NAMPTPRMT3SMN1; SMN2
SCHEMBL13328249 0.74 LMNA (0.60) ALDH1A1LMNAPKMNAMPTCNR1
SCHEMBL18860301 0.74 PIK3CD (0.44) LMNAPKMHPGDPIK3CD
SCHEMBL9893063 0.73 BRD4 (0.43) ALDH1A1NAMPTCNR2PRMT3
SCHEMBL21730473 0.72 ITGB3 (0.43) ALDH1A1NAMPTBCHESMN1; SMN2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118754-A1 COMPOUNDS RESPIVERT LTD. (GB) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118754-A1 COMPOUNDS LTC4S, CYP11B2, LTB4R2 ALDH1A1 224/4885LMNA 1817/4885PKM 1053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.